| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 264,820 | 248,614 | 233,697 | 255,719 | | Cost of Revenue | 113,812 | 196,138 | 182,144 | 198,841 | | | Gross Profit | 151,008 | 52,476 | 51,553 | 56,878 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 114,483 | 20,911 | 19,068 | 21,959 | | Non Recurring |
-
|
-
| 9,884 | 220,077 | | Others | 14,440 | 13,541 | 12,903 | 13,160 | | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 22,085 | 18,024 | 9,698 | (198,318) | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 10,161 | 10,385 | (9,725) | 328 | | Earnings Before Interest And Taxes | 32,720 | 28,925 | 491 | (197,574) | | Interest Expense | 6,042 | 6,653 | 7,067 | 5,556 | | Income Before Tax | 26,678 | 22,272 | (6,576) | (203,130) | | Income Tax Expense | 8,110 | 6,397 | 5,317 | 2,071 | | Minority Interest | (155) | (821) |
-
| 2,845 | | | | Net Income From Continuing Ops | 19,389 | 15,054 | (11,893) | (202,356) | | | Non-recurring Events | | Discontinued Operations | 452 | 146 | (61) | 540 | | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 18,865 | 15,200 | (11,954) | (201,816) | | Preferred Stock And Other Adjustments |
-
| 344 | (344) |
-
| | | Net Income Applicable To Common Shares | $18,865 | $15,544 | ($12,298) | ($201,816) |
|
0.03% Nasdaq 0.00%
Income Statement
